Psychological function in individuals with Amyotrophic Lateral Sclerosis (ALS)

Author(s): Brown WA, Mueller PS

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease classically defined by the impairment of the voluntary motor system and ubiquitin-positive intraneuronal aggregates in anterior horn cells. Frontotemporal dementia (FTD) is a common form of neurodegenerative dementia and presents with personality change associated in a significant subgroup of patients with cortical ubiquitin-only neuropathology (FTD-U). Careful study of ALS as well as FTD patient cohorts suggests clinical as well as pathological overlap of ALS with FTD. The idea that this reflects a shared pathogenesis has received strong support from the identification of new genetic loci on chromosome 9p and of mutations in specific genes (CHMP2B and DCN1) in families with co-segregation of ALS and FTD. The identification of two further genetic causes of FTD-U with (rare) ALS (PGRN) or without ALS (VCP) also provides a starting point for exploring the pathways associated with ubiquitin-mediated protein mishandling in FTD-U and ALS. Pure ALS, through ALS with cognitive impairment and ALS–FTD to pure FTD-U, may represent a continuous spectrum of ubiquitin-associated neurodegenerative disease.

Similar Articles

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease

Author(s): Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, et al.

Amyotrophic Lateral Sclerosis – Frontotemporal Spectrum Disorder (ALS-FTSD): Revised diagnostic criteria

Author(s): Strong MJ, Abrahams S, Goldstein LH, Wooley S, Mclaughlin P, et al.

Genetic counselling in ALS: facts, uncertainties and clinical suggestions

Author(s): Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, et al.

New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

Author(s): Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, et al.

ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis

Author(s): Lattante S, Pomponi MG, Conte A, Marangi G, Bisogni G, et al.

Pathological laughing and crying in amyotrophic lateral sclerosis

Author(s): McCullagh S, Moore M, Gawel M, Feinstein A

The El Escorial criteria: strengths and weakessnes

Author(s): Agosta F, Al-Chalabi A, Filippi M, Hairdman O, Kaji R, et al.

Cognitive changes predict functional decline in ALS: a polupaltion-based longitudinal study

Author(s): Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, et al.

Cognitive functioning in sporadic amyotrophic lateral sclerosis: A six month longitudinal study

Author(s): Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, et al.

Premorbid personality characteristics of patients with ALS

Author(s): Grossman AB, Bonnie EL, Bradley WG

Emotional Adjustment in Amyotrophic Lateral Sclerosis (ALS)

Author(s): Lulè D, Paulì S, Altinas E, Singer U, Mèrk T, et al.

Prevalence of Fatigue and depression in ALS patients and change over time

Author(s): McElhiney MC, Rabkin JC, Gordon PH, Goetz R, Mitsumoto H

Deficits in emotional and social cognition in Amyotrophic Lateral Sclerosis

Author(s): Girardi A, MacPherson SE, Abrahams S

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

Author(s): Lillo P, Savage S, Mioshui E, Kiernan MC, Hodges JR

La diagnosi in psichiatria

Author(s): Frances A

The cognitive profiles of ALS: A systematic review and meta-analisis update

Author(s): Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, et al.

Functional scales and motor assessment in Amyotrophic Lateral Sclerosis

Author(s): Benaim C, Desnuelle C, Fourniere-Mehouas M

The Amyotrophic Lateral Sclerosis Functional Rating Scale

Author(s): ALS CNTF Treatment Study (ACTS) Phase I-II Study Group

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

Author(s): Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, et al.